These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23019261)

  • 1. Molecular mechanisms of cortical degeneration in Parkinson disease.
    Shulman JM; Schneider JA
    Neurology; 2012 Oct; 79(17):1750-1. PubMed ID: 23019261
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Neurobiol Dis; 2019 Apr; 124():29-35. PubMed ID: 30408592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological changes of the isocortex in morbus Parkinson.
    Stockhausen P; Braak H
    Clin Neuropathol; 1984; 3(5):206-9. PubMed ID: 6499297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebral atrophy and dementia in Parkinson disease].
    Corthésy D; Hungerbühler JP; Assal G; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):75-85. PubMed ID: 2579429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease.
    Madhyastha TM; Askren MK; Boord P; Zhang J; Leverenz JB; Grabowski TJ
    Mov Disord; 2015 Dec; 30(14):1893-900. PubMed ID: 25759166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic denervation occurs early in Parkinson disease.
    Bohnen NI; Albin RL
    Neurology; 2009 Jul; 73(4):256-7. PubMed ID: 19535769
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
    Kawamoto Y; Ito H; Ihara M; Takahashi R
    Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Brenner SR
    Neurology; 2008 Jun; 70(23):2265; author reply 2265. PubMed ID: 18519878
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and pathological features of corticobasal degeneration.
    Gibb WR; Luthert PJ; Marsden CD
    Adv Neurol; 1990; 53():51-4. PubMed ID: 2239491
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
    Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter atrophy in early versus late dementia in Parkinson's disease.
    Beyer MK; Aarsland D
    Parkinsonism Relat Disord; 2008 Dec; 14(8):620-5. PubMed ID: 18394949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
    Shashidharan P; Good PF; Hsu A; Perl DP; Brin MF; Olanow CW
    Brain Res; 2000 Sep; 877(2):379-81. PubMed ID: 10986355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid homovanillic acid levels are not reduced in early corticobasal degeneration.
    Kanemaru K; Mitani K; Yamanouchi H
    Neurosci Lett; 1998 Apr; 245(2):121-2. PubMed ID: 9605500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caudato-pallido-nigral degeneration with cerebral atrophy: report of a case with parkinsonism and dementia.
    Tachibana H; Koto A; Fukuuchi Y; Ebihara S; Gotoh F; Kondo Y; Matsuyama H
    Keio J Med; 1984 Sep; 33(3):119-25. PubMed ID: 6513251
    [No Abstract]   [Full Text] [Related]  

  • 15. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterned cortical atrophy in early Parkinson's Disease: The potential for unbiased, data driven neuroimaging to detect structural changes in de novo patients.
    Walsh RR
    Parkinsonism Relat Disord; 2018 May; 50():1-2. PubMed ID: 29643008
    [No Abstract]   [Full Text] [Related]  

  • 17. Dementia with Lewy bodies and Parkinson disease with dementia: can MRI make the difference?
    Seppi K; Rascol O
    Neurology; 2007 Aug; 69(8):717-8. PubMed ID: 17709701
    [No Abstract]   [Full Text] [Related]  

  • 18. Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.
    Ferrer I
    Prog Neurobiol; 2009 Jun; 88(2):89-103. PubMed ID: 19482226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP activation and inflammatory reaction in selective neurodegeneration.
    Soós J
    Ideggyogy Sz; 2008 Mar; 61(3-4):136-9. PubMed ID: 18459454
    [No Abstract]   [Full Text] [Related]  

  • 20. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.
    Song SK; Lee JE; Park HJ; Sohn YH; Lee JD; Lee PH
    Mov Disord; 2011 Feb; 26(2):289-96. PubMed ID: 21370255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.